We just received data on a new analyst forecast for $CVRX. William Plovanic from Canaccord Genuity set a price target of 11.0 for CVRX.
To track analyst ratings and price targets for $CVRX, check out Quiver Quantitative's $CVRX forecast page.
Should you buy $CVRX?
Some analysts are better than others. To view the past performance of Canaccord Genuity, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$CVRX Price Targets
Multiple analysts have issued price targets for $CVRX recently. We have seen 2 analysts offer price targets for $CVRX in the last 6 months, with a median target of $12.0.
Here are some recent targets:
- Ross Osborn from Cantor Fitzgerald set a target price of $13.0 on 11/06/2025
- William Plovanic from Canaccord Genuity set a target price of $11.0 on 11/06/2025
$CVRX Insider Trading Activity
$CVRX insiders have traded $CVRX stock on the open market 7 times in the past 6 months. Of those trades, 7 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CVRX stock by insiders over the last 6 months:
- KIRK G. NIELSEN has made 4 purchases buying 198,779 shares for an estimated $1,037,141 and 0 sales.
- KEVIN HYKES (PRES & CEO) purchased 5,000 shares for an estimated $24,200
- MUDIT K. JAIN has made 2 purchases buying 1,650 shares for an estimated $7,774 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CVRX Hedge Fund Activity
We have seen 52 institutional investors add shares of $CVRX stock to their portfolio, and 46 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- EMERALD ADVISERS, LLC removed 590,850 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $3,474,198
- PARKMAN HEALTHCARE PARTNERS LLC removed 440,423 shares (-35.8%) from their portfolio in Q2 2025, for an estimated $2,589,687
- LORD, ABBETT & CO. LLC removed 396,763 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $2,332,966
- EMERALD MUTUAL FUND ADVISERS TRUST removed 369,672 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $2,173,671
- BALYASNY ASSET MANAGEMENT L.P. added 267,063 shares (+65.5%) to their portfolio in Q2 2025, for an estimated $1,570,330
- MARSHALL WACE, LLP added 246,548 shares (+238.1%) to their portfolio in Q2 2025, for an estimated $1,449,702
- CITADEL ADVISORS LLC removed 222,323 shares (-87.2%) from their portfolio in Q2 2025, for an estimated $1,307,259
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
